0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Toxicology
 1-20 of 864 Articles
JAMA Oncology | 
Brief Report |  ONLINE FIRST
Kenar D. Jhaveri, MD; Vipulbhai Sakhiya, MBBS; Steven Fishbane, MD
JAMA Oncol. Published online June 25, 2015. doi:10.1001/jamaoncol.2015.1713

JAMA Oncology | 
Invited Commentary |  ONLINE FIRST
Bart L. Scott, MD; Pamela S. Becker, MD, PhD
JAMA Oncol. Published online June 18, 2015. doi:10.1001/jamaoncol.2015.1591

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Animesh Pardanani, MD; Claire Harrison, MD; Jorge E. Cortes, MD; et al.
JAMA Oncol. Published online June 18, 2015. doi:10.1001/jamaoncol.2015.1590
Includes: Supplemental Content

JAMA | 
Medical News & Perspectives | 
Rita Rubin, MA
JAMA. 2015;313(23):2309-2310. doi:10.1001/jama.2015.3911.

JAMA Psychiatry | 
Original Investigation | 
Yaron Finkelstein, MD, ABCP(Dip); Erin M. Macdonald, MSc; Simon Hollands, MSc; et al.
JAMA Psychiatry. 2015;72(6):570-575. doi:10.1001/jamapsychiatry.2014.3188.
Includes: Supplemental Content

JAMA Dermatology | 
Original Investigation | 
Steven M. Belknap, MD; Imran Aslam, BS; Tina Kiguradze, BS; et al.
JAMA Dermatol. 2015;151(6):600-606. doi:10.1001/jamadermatol.2015.36.

JAMA Dermatology | 
Research Letter | 
Robert Denison Griffith, MD; Brian J. Simmons, BSc; Mohammad-Ali Yazdani Abyaneh, BSc; et al.
JAMA Dermatol. 2015;151(6):667-668. doi:10.1001/jamadermatol.2015.120.

JAMA Ophthalmology | 
Observation | 
Michael J. Koziolek, MD; Daniel Patschan, MD; Herbert Desel, MD; et al.
JAMA Ophthalmol. 2015;133(6):718-720. doi:10.1001/jamaophthalmol.2015.191.
Includes: Supplemental Content

JAMA Internal Medicine | 
Invited Commentary | 
Hillary V. Kunins, MD, MPH, MS
JAMA Intern Med. 2015;175(6):987-988. doi:10.1001/jamainternmed.2015.0939.

JAMA Internal Medicine | 
Original Investigation | 
Marc R. Larochelle, MD, MPH; Fang Zhang, PhD; Dennis Ross-Degnan, ScD; et al.
JAMA Intern Med. 2015;175(6):978-987. doi:10.1001/jamainternmed.2015.0914.
Includes: CME, Supplemental Content

JAMA Oncology | 
From The JAMA Network |  FREE ONLINE FIRST
Stacey L. Berg, MD; D. Williams Parsons, MD, PhD
JAMA Oncol. Published online May 28, 2015. doi:10.1001/jamaoncol.2015.1173

JAMA | 
News From the Food and Drug Administration | 
Rita Rubin, MA
JAMA. 2015;313(17):1704. doi:10.1001/jama.2015.4112.

JAMA Pediatrics | 
Research Letter | 
Terri Voepel-Lewis, PhD; Deborah Wagner, PharmD; Alan R. Tait, PhD
JAMA Pediatr. 2015;169(5):497-498. doi:10.1001/jamapediatrics.2014.3583.

JAMA Ophthalmology | 
Observation |  ONLINE FIRST
Sayali Pradhan, MD, FICO; Manoranjan Das, MD; Arun Kumar Panigrahi, MD; et al.
JAMA Ophthalmol. Published online April 30, 2015. doi:10.1001/jamaophthalmol.2015.0934

JAMA Dermatology | 
Research Letter |  ONLINE FIRST
Tarun Narang, MD; Gitesh U. Sawatkar, MD; Muthu Sendhil Kumaran, MD; et al.
JAMA Dermatol. Published online April 15, 2015. doi:10.1001/jamadermatol.2015.0384

JAMA Dermatology | 
Observation | 
Brian J. Simmons, BS; Robert D. Griffith, MD; Leyre A. Falto-Aizpurua, MD; et al.
JAMA Dermatol. 2015;151(4):454-456. doi:10.1001/jamadermatol.2014.4644.

JAMA Dermatology | 
Review | 
April W. Armstrong, MD, MPH; Jerry Bagel, MD; Abby S. Van Voorhees, MD; et al.
JAMA Dermatol. 2015;151(4):432-438. doi:10.1001/jamadermatol.2014.3456.

JAMA Neurology | 
Viewpoint | 
Carmen Kut, BS; Stuart A. Grossman, MD; Jaishri Blakeley, MD
JAMA Neurol. 2015;72(4):381-382. doi:10.1001/jamaneurol.2014.3736.

JAMA Internal Medicine | 
Original Investigation | 
Matthew Miller, MD, ScD; Catherine W. Barber, MPA; Sarah Leatherman, PhD; et al.
JAMA Intern Med. 2015;175(4):608-615. doi:10.1001/jamainternmed.2014.8071.
Includes: Supplemental Content

JAMA | 
Viewpoint | 
Rebecca L. Haffajee, JD, MPH; Anupam B. Jena, MD, PhD; Scott G. Weiner, MD, MPH
JAMA. 2015;313(9):891-892. doi:10.1001/jama.2014.18514.
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Brief Report  | 
Nephrotoxicity of the BRAF Inhibitors Vemurafenib and Dabrafenib
Kenar D. Jhaveri, MD; Vipulbhai Sakhiya, MBBS; Steven Fishbane, MD
JAMA Oncology
Invited Commentary  | 
JAK/STAT Pathway Inhibitors and Neurologic Toxicity: Above All Else Do No Harm?
Bart L. Scott, MD; Pamela S. Becker, MD, PhD
JAMA Oncology
Original Investigation  | 
Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis: A Randomized Clinical Trial
Animesh Pardanani, MD; Claire Harrison, MD; Jorge E. Cortes, MD; et al.
JAMA
Medical News & Perspectives  | 
Margaret A. Hamburg, MD, Reflects on 6 Years at FDA
Rita Rubin, MA